Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Nephrology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Kidney Disease Clinical Trials

A listing of Kidney Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1304) clinical trials

Diabetics are at a higher risk for chronic kidney disease since high blood sugar levels caused by diabetes damage blood vessels in the kidneys. If the blood sugar level remains high over many years, this damage gradually reduces the function of the kidneys. Your kidneys filter wastes and excess fluids ...

Phase

A Multicenter, Randomized, Open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with NDD-CKD Qualified Participants will receive at no cost to them. Study Medication Study Related Labs Physical Exams Rescue Medication Compensation for your time and travel for each completed study visit To Lean More ...

Phase

Qualified participants will receive at no cost to them: study medications study-related labs physicals and exams compensation for your time and travel for each visit

Phase N/A

Qualified participants will receive at no cost to them: study medications study-related labs physicals and exams compensation for your time and travel for each visit

Phase N/A

Patients affected by Autosomal Dominant Polycystic Kidney Disease (ADPKD) need a safe and effective long-term treatment regimen. Unfortunately, we still do not have any disease-specific treatment for ADPKD. A rational step towards identifying such agents is to test therapies that have a proven safety profile with mechanisms of action that ...

Phase N/A

The purpose of this research bio-repository study is to collect demographic, clinical, biochemical, histological, and genetic (RNA) data and samples from a large population of subjects with a variety of renal disease states, including diabetic, inflammatory, autoimmune and transplant related renal conditions, in order to assess for factors that may ...

Phase N/A

Evaluate the potential effect of hepatic or renal impairment on the pharmacokinetics, safety and tolerability of BAY 1841788 (ODM-201).

Phase

Demonstrate whether, in addition to standard of care finerenone is superior to placebo in delaying the progression of kidney disease, as measured by the composite endpoint of time to first occurrence of kidney failure , a sustained decrease of eGFR ≥ 40% from baseline over at least 4 weeks or ...

Phase